A retrospective, prospective, two-way cohort clinical study of kidney tonifying Chinese patent medicine on the growth and behavioral development of offspring after in vitro fertilization embryo tr
Phase 4
Recruiting
- Conditions
- Infertility
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1)The offspring of subjects who participated in a randomized, double-blind, placebo-controlled, multi-center clinical study of Zishen Yutai pill used in in vitro fertilization-embryo transfer treatment;
(2)The monthly age is 66±3 months or 78±3 months;
(3)The guardian agrees to participate in this study and signs an informed consent form.
Exclusion Criteria
No
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Behavior Scale Score;Gesell scale score (66±3 months subjects);Temperament scale score;Birth defect rate;Developmental indicators (height, weight, BMI, head circumference, chest circumference);Physical examination indicators;Webster's Intelligence Scale for Children (78±3 months of subjects);
- Secondary Outcome Measures
Name Time Method